Efficacy and safety of liraglutide versus sitagliptin, both in combination with metformin, in Chinese patients with type 2 diabetes: a 26‐week, open‐label, randomized, active comparator clinical trial

AIMS: To compare the efficacy and safety of liraglutide versus sitagliptin as add‐on to metformin after 26 weeks of treatment in Chinese patients with type 2 diabetes mellitus (T2DM). METHODS: This 26‐week open‐label, active comparator trial (NCT02008682) randomized patients (aged 18–80 years) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, L., Liu, Y., Geng, J., Luo, Y., Bian, F., Lv, X., Yang, J., Liu, J., Peng, Y., Li, Y., Sun, Y., Bosch‐Traberg, H., Mu, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084818/
https://www.ncbi.nlm.nih.gov/pubmed/27060930
http://dx.doi.org/10.1111/dom.12674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084818/
https://www.ncbi.nlm.nih.gov/pubmed/27060930
http://dx.doi.org/10.1111/dom.12674

Ejemplares similares